Cours GSRX Industries Inc. Other OTC
Actions
GSRX
US36255V1070
Produits pharmaceutiques
CA 2018 | 2,68 2,39 | CA 2019 | 11 9,8 | Capitalisation | 1,34 M 1,2 M |
---|---|---|---|---|---|
Résultat net 2018 | -16 M -14,25 M | Résultat net 2019 | -36 M -32,07 M | VE / CA 2018 | 26 486 381 x |
Trésorerie nette 2018 | 1,31 M 1,17 M | Dette nette 2019 | 2,27 M 2,02 M | VE / CA 2019 | 328 290 x |
PER 2018 |
-4,29
x | PER 2019 |
-0,03
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 13,26% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 10/03/20 |
Director of Finance/CFO | 63 | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 10/03/20 |
Jeff Rogers
BRD | Director/Board Member | 61 | 10/03/20 |
Shaun Dale
BRD | Director/Board Member | 47 | 23/04/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
+51,99% | 798 Md | |
-5,72% | 356 Md | |
+18,94% | 328 Md | |
+11,07% | 304 Md | |
+16,96% | 244 Md | |
+2,25% | 227 Md | |
+11,15% | 216 Md | |
+7,59% | 166 Md | |
-3,65% | 157 Md |